Question from Deputy Erin McGreehan - PQ 39556-26
Deputy McGreehan asked about eligibility criteria for patients applying under the Treatment Abroad Scheme. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy McGreehan asked about eligibility criteria for patients applying under the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Flynn asked if the performance of agency staffing suppliers are monitored nationally. Read the HSE response.
Deputy O'Flynn asked how are reimbursement decisions for high-cost orphan medicines are financially planned. Read the HSE response.
Deputy O'Flynn asked about the number of specialist assessments related to neurological complications associated with lyme disease from 2020 to 2026.
Deputy O'Flynn asked about the environmental impact of unused or expired medicines. Read the HSE response.
Deputy O'Flynn asked about the annual number of gender affirmation surgery applications approved under the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked whether the HSE reimburses medicines which are dispensed but never collected by patients. Read the HSE response.
Deputy O'Flynn asked about medication reviews for patients on multiple prescriptions. Read the HSE response.
Deputy O'Flynn asked if the HSE maintains a central register of high-cost treatment abroad scheme approvals. Read the HSE response.
Deputy O'Flynn asked about the number of confirmed lyme disease cases recorded annually since 2020. Read the HSE response.